News
Novo Nordisk has ended its partnership with Hims & Hers, citing concerns over the telehealth company’s promotion and sale of the drugmaker’s compounded versions of Wegovy. The drugmaker alleged that ...
Novo Nordisk is pulling the plug on its partnership with Hims & Hers Health over claims that the telehealth company sold fake versions of the pharmaceutical firm's weight-loss drug, Wegovy. The Danish ...
Novo Nordisk A/S scrapped a partnership with Hims & Hers Health Inc. after less than two months, saying the US company is ...
Novo Nordisk shares tumble 5.6% after ending Hims & Hers partnership and releasing disappointing CagriSema obesity drug trial ...
Sonakshi Sinha expresses pride as her film Nikita Roy releases alongside Kajol's Maa. She welcomes the box office clash as a positive moment for both actresses.
A quick introduction to Bitesize Scotland’s Poetry Podcast. Zara Janjua is joined by Jackie Kay to discuss six of her poems.
Gross profit margins are typically a sign of strong (or weak) pricing power and market share, and a 73% margin tells investors all they need to know. Hims & Hers is an industry leader, and its ...
Hims & Hers Health, a telehealth company, offers direct-to-patient platform to distribute prescription drugs and OTC ...
Novo Nordisk ends Wegovy deal with Hims over legal issues, sending the stock tumbling. What happens next? Here's a look.
Novo Nordisk ended its partnership with Hims & Hers on 23 June 2025, accusing the telehealth firm of selling unsafe, ...
Gwyneth Paltrow broke out white shorts for summer. While we think they’re a $650 pair from Max Mara, there’s an Amazon alternative that may also catch your eye. Shoppers praise the “flattering” ...
The loss of Novo’s involvement significantly dented investor confidence in Hims & Hers, plunging shares in the latter by 35% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results